Source:http://linkedlifedata.com/resource/pubmed/id/10452509
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1999-9-3
|
pubmed:abstractText |
Thirty-eight patients (25 women, 13 men; mean age, 57.8 [32 to 91]) showing one or more medullary thyroid microcarcinomas (ie, < 1 cm), with no prior MEN II or medullary thyroid carcinoma history in their family, were reviewed. Follow-up was available for 29 patients (mean, 53.6 months [1 to 147]). 21 patients (72.4%) are alive and free of disease, four patients (13.8%) died during follow-up without disease, 2 patients are alive with disease (local recurrence and persistent hypercalcitoninemia) after 80 and 99 months, respectively, and 2 patients died of disease after 24 and 46 months. Most tumors were incidental pathological findings (19 of 38) or were discovered by systematic blood calcitonin measurement for a nodular thyroid disease (15 of 38). Only the four patients who had an unfavorable outcome were symptomatic cases (palpable micro-MTC, diarrhea, cervical lymph node metastasis and pulmonary metastatic disease). The two patients with metastatic disease at diagnosis died during follow-up. In univariate analysis, a symptomatic medullary thyroid carcinoma was a strong predictor of an unfavourable outcome (p < .00008), as were the preoperative calcitonin level (P = .007) and an elevated postoperative calcitonin level (P = .004). Among 30 histopathological criteria, only the presence of amyloid correlated with an unfavorable outcome (P = .018).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0046-8177
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
957-63
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10452509-Adult,
pubmed-meshheading:10452509-Aged,
pubmed-meshheading:10452509-Aged, 80 and over,
pubmed-meshheading:10452509-Calcitonin,
pubmed-meshheading:10452509-Carcinoma, Medullary,
pubmed-meshheading:10452509-Female,
pubmed-meshheading:10452509-Humans,
pubmed-meshheading:10452509-Male,
pubmed-meshheading:10452509-Middle Aged,
pubmed-meshheading:10452509-Prognosis,
pubmed-meshheading:10452509-Retrospective Studies,
pubmed-meshheading:10452509-Survival Rate,
pubmed-meshheading:10452509-Thyroid Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial disease.
|
pubmed:affiliation |
Department of Pathology, Médecine C, Centre Hospitalier Universitaire, Angers, France.
|
pubmed:publicationType |
Journal Article
|